Feedback PLC
Company Profile
Business description
Feedback PLC develops and commercialises Bleepa, a UKCA-certified pathway management platform that enables healthcare professionals to share information, review diagnostics and manage patient pathways asynchronously across organisational boundaries. Its products include Bleepa, Imaging Engineering and Cadran PACS (Legacy), with Bleepa generating the maximum revenue. Its primary customers are NHS organisations, including hospitals, community diagnostic centres and integrated care systems. Its revenue is generated through software licence subscriptions, implementation services and long-term contracts. Its service areas include elective single point of access, transforming outpatient care, neighbourhood health services, and others.
Contact
3-7 Temple Avenue
201 Temple Chambers
LondonEC4Y 0DT
GBRT: +44 2039977634
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 May 2027
Employees
28
Stocks News & Analysis
stocks
CBA earnings: Business lending powers on, but costs and credit bear watching
stocks
Apple earnings review: Revenue beats estimates as memory crunch threatens margins
stocks
Nvidia: Cutting our fair value estimate by 19% given the firm’s CEO transition and turmoil
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,204.50 | 69.70 | -0.75% |
| CAC 40 | 8,368.91 | 7.55 | 0.09% |
| DAX 40 | 26,749.95 | 21.93 | -0.08% |
| Dow JONES (US) | 52,266.29 | 30.80 | -0.06% |
| FTSE 100 | 10,902.56 | 39.47 | 0.36% |
| HKSE | 23,637.60 | 370.95 | -1.55% |
| NASDAQ | 25,080.31 | 285.78 | -1.13% |
| Nikkei 225 | 61,142.35 | 322.99 | 0.53% |
| NZX 50 Index | 14,173.68 | 85.55 | -0.60% |
| S&P 500 | 7,543.17 | 49.23 | -0.65% |
| S&P/ASX 200 | 9,082.20 | 64.60 | -0.71% |
| SSE Composite Index | 3,634.35 | 21.48 | -0.59% |